Lipotoxicity in diabetic nephropathy: The potential role of fatty acid oxidation

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 12, 2010, Pages 2373-2379

  Murea, Mariana ^a   Freedman, Barry I ^a   Parks, John S ^a   Antinozzi, Peter A ^a   Elbein, Steven C ^a   Ma, Lijun ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NEPHRIN; PODOCIN; SATURATED FATTY ACID;

ADIPOCYTE; ALLELE; CYTOTOXICITY; DIABETIC NEPHROPATHY; FATTY ACID OXIDATION; GENETIC ASSOCIATION; GENOME; GLOMERULAR DYSFUNCTION; HUMAN; IMMUNOELECTRON MICROSCOPY; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; KIDNEY INJURY; LIPID RAFT; LIPID STORAGE; METABOLIC REGULATION; NONHUMAN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TUBULAR DYSFUNCTION;

ACETYL-COA CARBOXYLASE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FATTY ACIDS; HUMANS; OXIDATION-REDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78650325779     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08160910     Document Type: Review

References (49)

1. Garbarino J, Sturley SL: Saturated with fat: New perspectives on lipotoxicity. Curr Opin Clin Nutr Metab Care 12: 110-116, 2009
2. Muoio DM, Newgard CB: Fatty acid oxidation and insulin action: When less is more. Diabetes 57: 1455-1456, 2008
3. Schena FP, Gesualdo L: Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16[Suppl 1]: S30-S33, 2005
4. Tan AL, Forbes JM, Cooper ME: AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 27: 130-143, 2007
5. Maeda S, Kobayashi MA, Araki S, Babazono T, Freedman BI, Bostrom MA, Cooke JN, Toyoda M, Umezono T, Tarnow L, Hansen T, Gaede P, Jorsal A, Ng DP, Ikeda M, Yanagimoto T, Tsunoda T, Unoki H, Kawai K, Imanishi M, Suzuki D, Shin HD, Park KS, Kashiwagi A, Iwamoto Y, Kaku K, Kawamori R, Parving HH, Bowden DW, Pedersen O, Nakamura Y: A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet 6: e1000842, 2010
6. Tang SC, Leung VT, Chan LY, Wong SS, Chu DW, Leung JC, Ho YW, Lai KN, Ma L, Elbein SC, Bowden DW, Hicks PJ, Comeau ME, Langefeld CD, Freedman BI: The acetylcoenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetes. Nephrol Dial Transplant 2010 [Epub ahead of print]
7. Abe R, Minami J, Ohrui M, Ishimitsu T: Association of metabolic syndrome with urinary albumin excretion, lowgrade inflammation, and low glomerular filtration rate among non-diabetic Japanese subjects. Intern Med 48: 1855-1862, 2009
8. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358: 2545-2559, 2008 (Pubitemid 351831356)
9. The ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572, 2008
10. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383-393, 2003 (Pubitemid 36159355)
11. Gaede P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358: 580-591, 2008 (Pubitemid 351214285)
12. Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesaniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M: Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial. Lancet 366: 1849-1861, 2005
13. Fazio, S: More clinical lessons from the FIELD study. Cardiovasc Drugs Ther 23: 235-241, 2009
14. Bonnet F, Cooper ME: Potential influence of lipids in diabetic nephropathy: Insights from experimental data and clinical studies. Diabetes Metab 26: 254-264, 2000
15. Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M, Yoneda M, Matsuki M, Takigami S, Kaku K: Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis 40: 243-251, 2002 (Pubitemid 34827641)
16. Kume S, Uzu T, Araki S, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Kubota N, Terauchi Y, Kadowaki T, Haneda M, Kashiwagi A, Koya D: Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol 18: 2715-2723, 2007 (Pubitemid 47531198)
17. Wang Z, Jiang T, Li J, Proctor G, McManaman JL, Lucia S, Chua S, Levi M: Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 54: 2328-2335, 2005 (Pubitemid 41134259)
18. Jiang T, Wang XX, Scherzer P, Wilson P, Tallman J, Takahashi H, Li J, Iwahashi M, Sutherland E, Arend L, Levi M: Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Diabetes 56: 2485-2493, 2007 (Pubitemid 47523255)
19. Sun L, Halaihel N, Zhang W, Rogers T, Levi M: Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem 277: 18919-18927, 2002 (Pubitemid 34952453)
20. Park CW, Kim HW, Ko SH, Chung HW, Lim SW, Yang CW, Chang YS, Sugawara A, Guan Y, Breyer MD: Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha. Diabetes 55: 885-893, 2006
21. Li L, Emmett N, Mann D, Zhao X: Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy. Exp Biol Med (Maywood) 235: 383-391, 2010
22. Park CW, Zhang Y, Fan X, Davis L, Capdevila JH, Guan Y, Breyer MD: A PPAR alpha agonist improves diabetic nephropathy in db/db mice [Abstract]. J Am Soc Nephrol 14: 2003
23. Zhang Y, Park CW, Zheng F, Fan X, Striker G, Breyer MD, Guan Y: Endogenous PPARγ activity ameliorates diabetic nephropathy [Abstract]. J Am Soc Nephrol 14: 2003
24. Kimmelstiel P, Wilson C: Intercapillary lesions in the glomeruli of the kidney. Am J Pathol 12: 83-98, 1936
25. Lee HS, Lee JS, Koh HI, Ko KW: Intraglomerular lipid deposition in routine biopsies. Clin Nephrol 36: 67-75, 1991
26. Rosario RF, Prabhakar S: Lipids and diabetic nephropathy. Curr Diab Rep 6: 455-462, 2006
27. Keane WF: The role of lipids in renal disease: Future challenges. Kidney Int Suppl 75: S27-S31, 2000
28. Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176, 2000
29. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC: Myocardial fatty acid metabolism in health and disease. Physiol Rev 90: 207-258, 2010
30. Schaffer JE: Lipotoxicity: When tissues overeat. Curr Opin Lipidol 14: 281-287, 2003
31. Ratnayake WM, Galli C: Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: A background review paper. Ann Nutr Metab 55: 8-43, 2009
32. Kobayashi MA, Watada H, Kawamori R, Maeda S: Overexpression of acetyl-coenzyme A carboxylase beta increases proinflammatory cytokines in cultured human renal proximal tubular epithelial cells. Clin Exp Nephrol 14: 315-324, 2010
33. Guan Y: Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. J Am Soc Nephrol 15: 2801-2815, 2004
34. Berfield AK, Chait A, Oram JF, Zager RA, Johnson AC, Abrass CK: IGF-1 induces rat glomerular mesangial cells to accumulate triglyceride. Am J Physiol Renal Physiol 290: F138-F147, 2006
35. Jiang T, Wang Z, Proctor G, Moskowitz S, Liebman SE, Rogers T, Lucia MS, Li J, Levi M: Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem 280: 32317-32325, 2005
36. Ix JH, Sharma K: Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: The roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol 21: 406-412, 2010
37. Gerich JE: Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: Therapeutic implications. Diabet Med 27: 136-142, 2010
38. Kamijo Y, Hora K, Tanaka N, Usuda N, Kiyosawa K, Nakajima T, Gonzalez FJ, Aoyama T: Identification of functions of peroxisome proliferator-activated receptor alpha in proximal tubules. J Am Soc Nephrol 13: 1691-1702, 2002
39. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P: Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 108: 1621-1629, 2001
40. Simons M, Schwarz K, Kriz W, Miettinen A, Reiser J, Mundel P, Holthofer H: Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol 159: 1069-1077, 2001 (Pubitemid 32847197)
41. Huber TB, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlach E, Saleem MA, Walz G, Benzing T: Molecular basis of the functional podocin-nephrin complex: Mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet 12: 3397-3405, 2003 (Pubitemid 37541084)
42. Qin XS, Tsukaguchi H, Shono A, Yamamoto A, Kurihara H, Doi T: Phosphorylation of nephrin triggers its internalization by raft-mediated endocytosis. J Am Soc Nephrol 20: 2534-2545, 2009
43. Schermer B, Benzing T: Lipid-protein interactions along the slit diaphragm of podocytes. J Am Soc Nephrol 20: 473-478, 2009
44. Huber TB, Schermer B, Muller RU, Hohne M, Bartram M, Calixto A, Hagmann H, Reinhardt C, Koos F, Kunzelmann K, Shirokova E, Krautwurst D, Harteneck C, Simons M, Pavenstadt H, Kerjaschki D, Thiele C, Walz G, Chalfie M, Benzing T: Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci U S A 103: 17079-17086, 2006 (Pubitemid 44788925)
45. Schreiner GF: Renal toxicity of albumin and other lipoproteins. Curr Opin Nephrol Hypertens 4: 369-373, 1995
46. Susztak K, Ciccone E, McCue P, Sharma K, Bottinger EP: Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med 2: e45, 2005 (Pubitemid 40418903)
47. Okamura DM, Pennathur S, Pasichnyk K, Lopez-Guisa JM, Collins S, Febbraio M, Heinecke J, Eddy AA: CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. J Am Soc Nephrol 20: 495-505, 2009
48. Kim HJ, Moradi H, Yuan J, Norris K, Vaziri ND: Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol 296: F1297-F1306, 2009
49. Saito A, Sato H, Iino N, Takeda T: Molecular mechanisms of receptor-mediated endocytosis in the renal proximal tubular epithelium. J Biomed Biotechnol 2010: 403272, 2010